SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. “Michael is a ...
Appointment of Dr. Michael Kauffman to the Board of Directors brings extensive biotech leadership and expertise, particularly in oncology, which is crucial for progressing FibroGen's drug development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results